Monitoring of the National Mass Drug Administration Campaign for Lymphatic Filariasis Elimination in Narmada District, Gujarat: An Experience
DOI:
https://doi.org/10.51957/Healthline_728_2025Keywords:
Disease Eradication, Lymphatic Filariasis, Mass Drug AdministrationAbstract
This study evaluates MDA campaign in Gujarat for lymphatic filariasis elimination in the Narmada district. While ashram schools achieved 95% coverage, household compliance reached only 75% due to work conflicts, and migrant workers showed 80% uptake with mop-up challenges. Key barriers included medical condition-related refusals (60%), fear of side effect of medication (30%), and documentation gaps (40%). Implementation challenges involved poor timing (missing 25% workers), exclusion of commercial sectors, and weak coordination. Successful institutional delivery models contrasted with gaps requiring: 1) adjusted distribution timings, 2) targeted counselling for chronic patients, 3) workplace-based MDA, and 4) enhanced digital IEC in local dialects. The findings emphasise the need for improved microplanning, real-time monitoring, and private-sector integration. These results demonstrate that tailored approaches targeted working populations, migrants, and comorbid patients can significantly improve compliance. The study provides actionable recommendations to strengthen MDA implementation, supporting India's 2027 elimination target through context-specific strategies that address ground-level challenges while leveraging successful institutional models.
References
1. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2023. Wkly Epidemiol Rec. 2024;99(5):45-60
2. National Centre for Vector Borne Diseases Control (NCVBDC). Annual Report on Lymphatic Filariasis Elimination in India, 2024. New Delhi: MoHFW; 2024
3. Press Information Bureau. Union Health Minister launches nationwide MDA for Lymphatic Filariasis elimination. Government of India. 2025 Feb 10. Available from: https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2101250
4. Patel RK, Desai VK, Solanki HK. Coverage and compliance of mass drug administration for lymphatic filariasis in rural Gujarat: A cross-sectional study. Indian J Community Med. 2023;48(2):210-215. doi: 10.4103/ijcm.ijcm_921_22
5. Lahariya C, Mishra A. Strengthening mass drug administration for lymphatic filariasis elimination in India: A review. Trop Med Health. 2024;52:12. doi: 10.1186/s41182-024-00578-4 DOI: https://doi.org/10.1186/s41182-024-00578-4
Downloads
Published
License
Copyright (c) 2025 Arihant Jain, Lincy Ableen Lakra, S.K. Rasania (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in "Healthline Journal" are Open Access articles. The license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited, and the new creations are licensed under the identical terms.
